GlassScriptPhysician profile
Timur Sarac
NPI 1457316234
$11,647.12
in general payments reported to CMS, 2019-2025
15 companies · $840 in 2025
The $840 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $990 · 2021: $143 · 2022: $3,785 · 2023: $3,940 · 2024: $1,390 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,291 · Travel and Lodging: $980 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,290.63 |
| Travel and Lodging | $979.80 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $5,294.95 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Shape Memory Medical INC. | $2,303.82 | 2022-2025 | Impede Embolization Plug |
| Convatec INC. | $900.00 | 2023 | |
| Bard Peripheral Vascular, INC. | $853.58 | 2022-2024 | Lutonix Drug Coated Balloon, Crosser Iq |
| Bolton Medical INC | $517.93 | 2022-2024 | Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $316.72 | 2024-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| Penumbra, INC. | $314.32 | 2022-2025 | Indigo System |
| Heartflow, INC. | $281.83 | 2021-2025 | |
| Inari Medical, INC. | $197.84 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $193.91 | 2023 | Jeti Peripheral Catheter, Jeti |
| Cook Medical LLC | $158.67 | 2025 | Zenith Spiral-Z, Zilver Vena |
| Boston Scientific Corporation | $131.58 | 2022 | |
| Getinge USA Sales, LLC | $112.08 | 2019 | |
| Dilon Technologies, INC. | $69.89 | 2024-2025 | Hemoblast Bellows |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timur Sarac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.